Pfiz­er names a VC leader in year of re­set; For­mer Ax­cel­la CEO moves on af­ter com­pa­ny shut­down

→ A spokesper­son for Pfiz­er tells Peer Re­view that Michael Diem has joined the phar­ma gi­ant as head of ven­ture cap­i­tal & eq­ui­ty in­vest­ments. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.